A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
Background: Biliary tract carcinoma (BTC) is rare in the West, but not uncommon in Asia and is a highly fatal malignancy. VEGF expression is related with poor outcome in patients with BTC. Therefore, we conducted a phase II study to evaluate the efficacy and safety of sunitinib as second-line treatm...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | 雜誌 |
| 出版: |
2017
|
| 在線閱讀: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84655161964&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/42930 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|